Are There Specific Biomarkers That Predict Peptide Therapy Efficacy for Metabolic Disorders?
Biomarkers like IGF-1, fasting insulin, and adipokines can indicate metabolic status and guide peptide therapy, reflecting responsiveness rather than strict prediction.
HRTioJuly 19, 2025